Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- Resource Type
- Article
- Authors
- Bruix, Jordi; Takayama, Tadatoshi; Mazzaferro, Vincenzo; Chau, Gar-Yang; Yang, Jiamei; Kudo, Masatoshi; Cai, Jianqiang; Poon, Ronnie T; Han, Kwang-Hyub; Tak, Won Young; Lee, Han Chu; Song, Tianqiang; Roayaie, Sasan; Bolondi, Luigi; Lee, Kwan Sik; Makuuchi, Masatoshi; Souza, Fabricio; Berre, Marie-Aude Le; Meinhardt, Gerold; Llovet, Josep M
- Source
- In The Lancet Oncology October 2015 16(13):1344-1354
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045